WFS1 Gene Deafness autosomal dominant type 6 Genetic Test
Components: WFS1 Gene Deafness autosomal dominant type 6 Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Ear Nose Throat Disorders
Doctor: ENT Doctor
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN27
Test Details
The WFS1 gene is associated with a type of deafness known as autosomal dominant type 6 (DFNA6). This type of deafness is inherited in an autosomal dominant pattern, which means that an affected individual has a 50% chance of passing the condition on to each of their children.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of WFS1 gene deafness, NGS genetic testing can be used to identify any mutations or variations in the WFS1 gene that may be causing the deafness.
NGS genetic testing is a powerful tool in genetic diagnosis as it allows for a comprehensive analysis of multiple genes at once, providing a more efficient and cost-effective approach compared to traditional sequencing methods. It can help in confirming a diagnosis, determining the mode of inheritance, and providing information for genetic counseling and family planning.
If an individual suspects they have DFNA6 or a healthcare provider suspects this condition based on symptoms, NGS genetic testing can be ordered to analyze the WFS1 gene and potentially identify any pathogenic variants that may be responsible for the deafness. This information can be valuable in understanding the underlying cause of the condition and guiding appropriate management and treatment options.
Test Name | WFS1 Gene Deafness autosomal dominant type 6 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ear Nose Throat Disorders |
Doctor | ENT Doctor |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN27 |
Test Details |
The WFS1 gene is associated with a type of deafness known as autosomal dominant type 6 (DFNA6). This type of deafness is inherited in an autosomal dominant pattern, which means that an affected individual has a 50% chance of passing the condition on to each of their children. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of WFS1 gene deafness, NGS genetic testing can be used to identify any mutations or variations in the WFS1 gene that may be causing the deafness. NGS genetic testing is a powerful tool in genetic diagnosis as it allows for a comprehensive analysis of multiple genes at once, providing a more efficient and cost-effective approach compared to traditional sequencing methods. It can help in confirming a diagnosis, determining the mode of inheritance, and providing information for genetic counseling and family planning. If an individual suspects they have DFNA6 or a healthcare provider suspects this condition based on symptoms, NGS genetic testing can be ordered to analyze the WFS1 gene and potentially identify any pathogenic variants that may be responsible for the deafness. This information can be valuable in understanding the underlying cause of the condition and guiding appropriate management and treatment options. |